Company intelligence / Profile preview

Intelomed

Pittsburgh, Pennsylvania, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

Intelomed developed the CVInsight™ non-invasive patient-monitoring platform to provide real-time insights into cardiovascular stress for at-risk patients. The technology aimed to improve early detection and intervention for conditions like heart failure and hemodialysis-related instability. As of the latest reports, it had completed proof-of-concept studies with $3.85 million raised for further validation and commercialization efforts.

Therapeutic areas: Cardiovascular
Modalities: Device (non-invasive patient monitoring platform)Non-pharmacological therapy (monitoring/informatics)
Industry: Physiological Monitoring

Drug pipeline

1 asset

CVInsight

Commercial

Indications: Cardiovascular monitoring, Dialysis monitoring

Beyond the preview

Go deeper on Intelomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intelomed.

Explore the full profile